deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT03117920

A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer (MinPAC)

MinPAC: A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer.

Sponsor: Barts & The London NHS Trust

Conditions Pancreatic Cancer
Interventions Minnelide
Updated 11 times since 2017 Last updated: Oct 17, 2023 Started: Apr 10, 2017 Primary completion: Jul 1, 2019 Completion: Jul 1, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03117920, this PHASE2 trial focuses on Pancreatic Cancer and remains completed. Sponsored by Barts & The London NHS Trust, it has been updated 11 times since 2017, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jun 2017 – ~Sep 2017 · 3 months · monthly snapshotRecruiting~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotRecruiting~Jun 2018 – ~Oct 2019 · 16 months · monthly snapshotRecruiting~Oct 2019 – ~Feb 2020 · 4 months · monthly snapshotUnknown Status~Feb 2020 – ~May 2020 · 3 months · monthly snapshotActive Not Recruiting~May 2020 – ~Oct 2020 · 5 months · monthly snapshotActive Not Recruiting~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotCompleted~Jan 2021 – ~Nov 2023 · 34 months · monthly snapshotCompleted~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Nov 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Nov 2023 [monthly]

    Completed PHASE2

  5. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

▶ Show 6 earlier versions

  1. May 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE2

  2. Feb 2020 — May 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: Unknown Status → Active Not Recruiting

  3. Oct 2019 — Feb 2020 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  4. Jun 2018 — Oct 2019 [monthly]

    Recruiting PHASE2

  5. Sep 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  6. Jun 2017 — Sep 2017 [monthly]

    Recruiting PHASE2

    First recorded

Apr 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Barts & The London NHS Trust
  • Cancer Research UK
  • Lustgarten Foundation
  • Minneamrita Therapeutics LLC
  • Queen Mary University of London
  • Stand Up To Cancer
  • Translational Genomics Research Institute
Data source: Minneamrita Therapeutics LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations